Deploying Minimally Invasive Transplant Tests in Kidney Disease Treatment
Tina Liedtky
Minimally invasive testing options can be less risky and less expensive compared to traditional, invasive biopsies
Kidney Disease
‘Concierge’ Screening for Kidney Transplant Candidates Leads to Better Outcomes, Study Finds
University of New Mexico Health Sciences Center
The new testing approach also resulted in greater revenue for the transplant center
New Drug Controls Sickle Cell Disease-Linked Hypertension
University of Maryland School of Medicine
Treatment for lung condition could help patients with SCD control complications from hypertension and kidney damage
Organoids Help Uncover the Genetics of Kidney Disease
National Institutes of Health
Innovative disease modeling and gene editing techniques begin to answer long-standing questions
New Test Drug–Empagliflozin Combo Abates CKD Side Effects
UW Medicine
Some 70 percent of patients who received the test drug with a standard-care drug experienced a significant drop in albuminuria
Utilizing a Commercially Validated CE-IVD Marked Steroid Panel
Tecan Trading AG
New panel offers accurate dexamethasone measurement from serum or plasma CS diagnosis
Novel Drug Improves Rare Kidney Disorder in Phase 3 Trial
University of Minnesota Medical School
Some 42 percent of patients treated with sparsentan showed reduced proteinuria
Deep Learning Unlocks Valuable Cancer Biology Clues
Dana-Farber Cancer Institute
AI models uncover patterns across two-dimensional images of tumor samples that could help predict response to immunotherapy
What’s New in Histology?
Michael Schubert, PhD
Recent news from the world of tissue-based diagnostics
Novel Biomarkers Predict Heart, Kidney Disease in People with T2D
American Heart Association
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers